BilateralProphylacticMastectomyAromataseInhibitorsGeneticCounselingMethotrexateGuaranteedRenewableInsuranceAyurvedaImmunotherapyBI-RADSRADDoseDenseTherapyCAMFlowCytometryAntibodyTherapyER+/-PathologicResponseCalcificationsKi-67RateAdvocacyStagingLump5-FluorouracilFISHOvarianSuppressionTamoxifenAbsoluteRiskGailModelCytotoxicHER-2CMFChemotherapyCystCDK4/6InhibitorsMetastasisAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltHormoneReplacementTherapyPagetDiseaseBiopsyMRICyclophosphamideCheckpointInhibitorPalpationRadiotherapyChemoprevention1 in 8womenAdjuvantTherapyWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.BreastCancerEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearDown-StagingMegestrolAcetateRaloxifeneAdenocarcinomaKappaEpsilonECOGScoreGeneticPredispositionPhyllodesTumorWomen ages40+ shouldhave a clinicalbreast examat least yearlyAlopeciaEstrogen/EstradiolBrachytherapyAngiogenesisAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerSelf-examinationGermlineMutationTumorGradeBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55LymphoscintigraphyDimplingBOCAPI3KinaseInhibitorsDoxorubicinAnastrozoleAntiemeticsSERMFamilyHistoryOligometastasesMastodyniaCytostaticLCISBRCAGeneHormoneReceptorStatusmTORInhibitorsChemotherapyApoptosisDefinitiveSurgeryProgestinIntraductalPapillomaLymphNodeStatusMastectomyCachexiaPhysicalactivity mayreduce therisk of breastcancersEGFRDocetaxelPrecisionMedicineMultifocalTumorsLumpectomyHerceptinMorpheaACChemotherapyTriple +/-BreastCancerPalbociclibLapatinibMultimodalityTherapyBevacizumabRelapseGeneMutationNeoadjuvantTherapyFibroadenomaCo-survivorTyrosine-KinaseInhibitorBreastTomosynthesisFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.CapecitabinePaclitaxelIn-situCarcinomaPARPInhibitorsBilateralProphylacticMastectomyAromataseInhibitorsGeneticCounselingMethotrexateGuaranteedRenewableInsuranceAyurvedaImmunotherapyBI-RADSRADDoseDenseTherapyCAMFlowCytometryAntibodyTherapyER+/-PathologicResponseCalcificationsKi-67RateAdvocacyStagingLump5-FluorouracilFISHOvarianSuppressionTamoxifenAbsoluteRiskGailModelCytotoxicHER-2CMFChemotherapyCystCDK4/6InhibitorsMetastasisAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltHormoneReplacementTherapyPagetDiseaseBiopsyMRICyclophosphamideCheckpointInhibitorPalpationRadiotherapyChemoprevention1 in 8womenAdjuvantTherapyWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.BreastCancerEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearDown-StagingMegestrolAcetateRaloxifeneAdenocarcinomaKappaEpsilonECOGScoreGeneticPredispositionPhyllodesTumorWomen ages40+ shouldhave a clinicalbreast examat least yearlyAlopeciaEstrogen/EstradiolBrachytherapyAngiogenesisAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerSelf-examinationGermlineMutationTumorGradeBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55LymphoscintigraphyDimplingBOCAPI3KinaseInhibitorsDoxorubicinAnastrozoleAntiemeticsSERMFamilyHistoryOligometastasesMastodyniaCytostaticLCISBRCAGeneHormoneReceptorStatusmTORInhibitorsChemotherapyApoptosisDefinitiveSurgeryProgestinIntraductalPapillomaLymphNodeStatusMastectomyCachexiaPhysicalactivity mayreduce therisk of breastcancersEGFRDocetaxelPrecisionMedicineMultifocalTumorsLumpectomyHerceptinMorpheaACChemotherapyTriple +/-BreastCancerPalbociclibLapatinibMultimodalityTherapyBevacizumabRelapseGeneMutationNeoadjuvantTherapyFibroadenomaCo-survivorTyrosine-KinaseInhibitorBreastTomosynthesisFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.CapecitabinePaclitaxelIn-situCarcinomaPARPInhibitors

BOCA Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
  1. Bilateral Prophylactic Mastectomy
  2. Aromatase Inhibitors
  3. Genetic Counseling
  4. Methotrexate
  5. Guaranteed Renewable Insurance
  6. Ayurveda
  7. Immunotherapy
  8. BI-RADS
  9. RAD
  10. Dose Dense Therapy
  11. CAM
  12. Flow Cytometry
  13. Antibody Therapy
  14. ER +/-
  15. Pathologic Response
  16. Calcifications
  17. Ki-67 Rate
  18. Advocacy
  19. Staging
  20. Lump
  21. 5-Fluorouracil
  22. FISH
  23. Ovarian Suppression
  24. Tamoxifen
  25. Absolute Risk
  26. Gail Model
  27. Cytotoxic
  28. HER-2
  29. CMF Chemotherapy
  30. Cyst
  31. CDK4/6 Inhibitors
  32. Metastasis
  33. African-American women have a lower chance of breast cancer overall, but they are 40% more likely to die from breast cancer than white women
  34. Mammography is a low-dose X-ray examination that can detect breast cancer two years before it is large enough to be felt
  35. Hormone Replacement Therapy
  36. Paget Disease
  37. Biopsy
  38. MRI
  39. Cyclophosphamide
  40. Checkpoint Inhibitor
  41. Palpation
  42. Radiotherapy
  43. Chemoprevention
  44. 1 in 8 women
  45. Adjuvant Therapy
  46. Women ages 20-39 yo should have a clinical breast exam at least every 3 years.
  47. Breast Cancer
  48. Estimated 2,150 men will be diagnosed with breast cancer and approximately 410 will die each year
  49. Down-Staging
  50. Megestrol Acetate
  51. Raloxifene
  52. Adenocarcinoma
  53. Kappa Epsilon
  54. ECOG Score
  55. Genetic Predisposition
  56. Phyllodes Tumor
  57. Women ages 40+ should have a clinical breast exam at least yearly
  58. Alopecia
  59. Estrogen/Estradiol
  60. Brachytherapy
  61. Angiogenesis
  62. Alcohol intake of more than two drinks per day is a risk factor for breast cancer
  63. Self-examination
  64. Germline Mutation
  65. Tumor Grade
  66. Breast cancer is the leading cause of death in women between the ages of 40 and 55
  67. Lymphoscintigraphy
  68. Dimpling
  69. BOCA
  70. PI3 Kinase Inhibitors
  71. Doxorubicin
  72. Anastrozole
  73. Antiemetics
  74. SERM
  75. Family History
  76. Oligometastases
  77. Mastodynia
  78. Cytostatic
  79. LCIS
  80. BRCA Gene
  81. Hormone Receptor Status
  82. mTOR Inhibitors
  83. Chemotherapy
  84. Apoptosis
  85. Definitive Surgery
  86. Progestin
  87. Intraductal Papilloma
  88. Lymph Node Status
  89. Mastectomy
  90. Cachexia
  91. Physical activity may reduce the risk of breast cancers
  92. EGFR
  93. Docetaxel
  94. Precision Medicine
  95. Multifocal Tumors
  96. Lumpectomy
  97. Herceptin
  98. Morphea
  99. AC Chemotherapy
  100. Triple +/- Breast Cancer
  101. Palbociclib
  102. Lapatinib
  103. Multimodality Therapy
  104. Bevacizumab
  105. Relapse
  106. Gene Mutation
  107. Neoadjuvant Therapy
  108. Fibroadenoma
  109. Co-survivor
  110. Tyrosine-Kinase Inhibitor
  111. Breast Tomosynthesis
  112. For every 1,000 screening mammograms performed, about five breast cancers are detected.
  113. Capecitabine
  114. Paclitaxel
  115. In-situ Carcinoma
  116. PARP Inhibitors